🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Min Xiao

Harbin Medical University

ORCID: 0000-0001-9421-6344

Also affiliated with Third Affiliated Hospital of Harbin Medical University

Biochemistry, Genetics and Molecular BiologyMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.652Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014
Top 31%
0.652DataRank
Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Papers

Driven by 16 papers — median percentile 35. Top paper: “Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy”.

Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy

Nature Communications(2021)10.1038/s41467-020-20600-7
N/A
0.784DataRank · unranked
185 citations

Thomas Connelly, Robin Choi, Hyeree Choi, Anastasia Samarkina, Ling Li +52 more

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014
Top 31%
0.652DataRank
Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma

Oncogene(2021)10.1038/s41388-021-01911-5
N/A
0.624DataRank · unranked
63 citations

Wei Zhang, Gao Zhang, Lawrence N. Kwong, Hezhe Lu, Jiufeng Tan +17 more

Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2773
N/A
0.574DataRank · unranked
45 citations

Varsha Thakur, Yuan Li, Juliano T. Freitas, Patrick M. Zmina, Vijay S. Thakur +16 more

Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance

Cancer Research(2021)10.1158/0008-5472.can-20-1496
N/A
0.489DataRank · unranked
25 citations

Vito W. Rebecca, Andrew V. Kossenkov, Thomas Connelly, Qin Liu, Alexis Gutierrez +43 more

Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.20.524923
N/A
0.269DataRank · unranked
5 citations

Min Xiao, Andrew V. Kossenkov, Tetiana Godok, Gregory Schuyler Brown, Dylan Fingerman +13 more

Data from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

(2023)10.1158/2159-8290.c.6549364
N/A
0DataRank · unranked
1 citations

Tamer A. Ahmed, Maxwell R. Tucker, Peter M.U. Ung, Min Xiao, Zoi Karoulia +12 more

Data from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma

(2023)10.1158/1078-0432.c.6529614
N/A
0DataRank · unranked
0 citations

Varsha Thakur, Yuan Li, Juliano T. Freitas, Patrick M. Zmina, Vijay S. Thakur +16 more

Data from Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas

(2023)10.1158/1535-7163.c.6532010
N/A
0DataRank · unranked
0 citations

Mercedes Lioni, Maurizia Dalla Palma, Min Xiao, Brijal Desai, Suzanne Egyházi +9 more

Data from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma

(2023)10.1158/1078-0432.c.6529614.v1
N/A
0DataRank · unranked
0 citations

Varsha Thakur, Yuan Li, Juliano T. Freitas, Patrick M. Zmina, Vijay S. Thakur +16 more

Data from Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas

(2023)10.1158/1535-7163.c.6532010.v1
N/A
0DataRank · unranked
0 citations

Mercedes Lioni, Maurizia Dalla Palma, Min Xiao, Brijal Desai, Suzanne Egyházi +9 more

Notch1 signaling determines the plasticity and function of fibroblasts in diabetic wounds

Life Science Alliance(2020)10.26508/lsa.202000769
N/A
0DataRank · unranked
32 citations

Yan Li, Irena Pastar, Min Xiao, Rochelle Prokupets, Sophia Liu +6 more

Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1351
N/A
0DataRank · unranked
65 citations

Tamer A. Ahmed, Maxwell R. Tucker, Peter M.U. Ung, Min Xiao, Zoi Karoulia +12 more

ClampFISH 2.0 enables rapid, scalable amplified RNA detection in situ

Nature Methods(2022)10.1038/s41592-022-01653-6
N/A
0DataRank · unranked
47 citations

Benjamin Emert, Yogesh Goyal, Connie Jiang, Amanpreet Kaur, Jasmine Lee +8 more

A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.26.512745
Top 100%
0DataRank
Top 100%0 citations

X. Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +45 more

Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity

Cell Reports(2023)10.1016/j.celrep.2023.113224
N/A
0DataRank · unranked
78 citations

Youtao Lu, Xuexiang Han, Jingbo Yang, Zhiyuan Qin, Wei Zhang +20 more